Phase I dose escalation study of TG02 in patients with advanced hematologic malignancies.
Gail J. Roboz
No relevant relationships to disclose
Hanna Jean Khoury
No relevant relationships to disclose
Jamile M. Shammo
No relevant relationships to disclose
Mary Syto
Stock Ownership - Tragara Pharmaceuticals
Francis Burrows
Stock Ownership - Tragara Pharmaceuticals
Sara L. Zaknoen
Stock Ownership - Tragara Pharmaceuticals
Elias Jabbour
No relevant relationships to disclose